Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML

Blood(2023)

引用 0|浏览1
暂无评分
摘要
•A new TCR mimic mAb specific for the WT1-derived epitope RMF presented by HLA-A2, ESK2, was developed.•ESK2 was engineered into a new CAR-T format, AbTCR-CSR, which comprises primary and CSR, directed against two antigens, WT1 and CD33 in AML.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要